Edition: Australia  
One News Page
“Probably the fastest-access news portal in the world”
> >

Clovis Oncology's cancer drug Rubraca succeeds in key study

Reuters Monday, 19 June 2017
(Reuters) - Clovis Oncology Inc said its ovarian cancer drug Rubraca slowed disease progression in a late-stage trial involving patients with various gene mutations who had undergone initial therapy.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

You Might Like


Other recent news in Health

BUDGET 2017: Chancellor on funding for NHS in EnglandMinimum alcohol pricing in SCOTLAND to start in May
Health CANADA doesn't know if its dental programs benefiting Indigenous Canadians: reportAUSTRALIA's Victoria state closer to legalizing assisted death
David Cassidy, 'PARTRIDGE FAMILY' Star, Dies at 67BIG TOBACCO's anti-smoking ads begin after decade of delay
From 'Inky's Great Escape' To Singing Seahorses: Animal Books For The HOLIDAYS

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+